Skip to content
Cancer Institute NSW sites
eviQ Education
Learning resources for cancer staff
opens in a new tab or window
Cancer Institute NSW
NSW cancer control agency
opens in a new tab or window
Patient Information
Practical advice about cancer
opens in a new tab or window
Canrefer
Find a cancer specialist
opens in a new tab or window
BreastScreen NSW
Detect breast cancer early
opens in a new tab or window
Cervical Screening NSW
Cervical Screening NSW
opens in a new tab or window
iCanQuit
Learn how to quit smoking
opens in a new tab or window
Log in
Register
Search
Search
Log in
Register
Search
Main menu Toggle menu collaspe
Search eviQ
Close
Search
Search
Home
Home
Cancer genetics
Adult
Genetic testing for heritable pathogenic variants
Genetic testing using cancer gene panels
Risk management
Paediatric
Genetic testing for heritable pathogenic variants
Genetic testing using cancer gene panels
Risk management
Referral guidelines
Consumer information
Resources
Haematology and BMT
Leukaemias
Acute lymphoblastic leukaemia
Acute myeloid leukaemia
Acute promyelocytic leukaemia
Chronic lymphocytic leukaemia
Chronic myeloid leukaemia
Hairy cell leukaemia
Myelodysplastic disorders
Lymphoma
Hodgkin lymphoma
Burkitt lymphoma
Mantle cell lymphoma
NK-cell and T-cell lymphoma
Other B-cell lymphoma
Primary CNS lymphoma
Waldenstrom macroglobulinaemia
Multiple myeloma
Blood and marrow transplant
Mobilisation
Allogeneic
Autologous
GVHD prophylaxis
Cellular therapies
Medical oncology
Breast
Neoadjuvant/Adjuvant
Metastatic
Colorectal
Adjuvant and neoadjuvant
Metastatic
Anal
Rectal
Gynaecological
Cervical
Endometrial
Gestational trophoblastic disease
Ovarian
Vulval
Head and neck
Definitive chemoradiation
Induction chemotherapy
Nasopharyngeal
Post operative chemoradiation
Recurrent or metastatic
Salivary gland
Thyroid
Neurological
Glioma
Respiratory
Mesothelioma
Non small cell lung cancer - Adjuvant/neoadjuvant
Non small cell lung cancer - Advanced/metastatic
Small cell lung cancer
Sarcoma
Soft tissue sarcoma
Bone sarcoma
Skin
Melanoma neoadjuvant/adjuvant
Melanoma metastatic
Non-melanoma
Upper gastrointestinal
Gastric and oesophageal adjuvant and neoadjuvant
Gastric and oesophageal metastatic
Gastrointestinal stromal cell tumours
Hepatic
Neuroendocrine
Pancreas and biliary
Urogenital
Adrenocortical
Bladder and Urothelial
Prostate
Renal
Testicular
Penile
Rare cancers
Colorectal
Gynaecological
Head and neck
Melanoma
Neurological
Respiratory
Sarcoma
Upper gastrointestinal
Urogenital
Tumour-agnostic
Tumour-agnostic
Radiation oncology
Breast
Colorectal
Gynaecological
Haematology
Head and neck
Neurological
Palliative
Respiratory
Upper gastrointestinal
Urogenital
Bladder
Prostate
Kidney and adrenal
Skin
Stereotactic
Clinical resources
eviQ calculators
Aboriginal health workers
ADDIKD guideline
Administration of anti-cancer drugs
Assessment tools
BMT & cellular therapies
Central venous access devices (CVADs)
Day of Treatment Assessment
Extravasation
Pumps
Health professional fact sheets
Oncological emergencies
Radiation oncology
Assessment tools
Cardiac implantable electronic devices
Contrast administration
Radiation-induced dermatitis
Side effect and toxicity management
Side effect and toxicity management
Cardiovascular
Gastrointestinal
General
Genitourinary
Gynaecological
Haematological
Hair, skin and nails
Immunological
Neurological and sensory
Oropharyngeal
Prophylaxis and treatment
Reproductive
Respiratory
Telephone triage toolkit
Patients and carers
Anticancer drug treatments
Radiation therapy treatments
Cancer genetics information sheets
Patient information sheets
At home
Cancer type specifics
Complementary and alternative medicines
Eating and drinking
Fertility, sex, pregnancy and breastfeeding
Treating cancer with medicines
How you have anticancer medicine treatment
Treating cancer with radiation therapy
Managing side effects
Vaccinations
Your family and friends
Patient information in other languages
عربى (Arabic)
简 (Simplified Chinese)
繁 (Traditional Chinese)
Français (French)
Ελληνικά (Greek)
Italiano (Italian)
한국어 (Korean)
Español (Spanish)
Tiếng Việt (Vietnamese)
Македонски (Macedonian)
ไทย (Thai)
Patient information videos
Cancer Institute NSW sites
eviQ Education
Learning resources for cancer staff
opens in a new tab or window
Cancer Institute NSW
NSW cancer control agency
opens in a new tab or window
Patient Information
Practical advice about cancer
opens in a new tab or window
Canrefer
Find a cancer specialist
opens in a new tab or window
BreastScreen NSW
Detect breast cancer early
opens in a new tab or window
Cervical Screening NSW
Cervical Screening NSW
opens in a new tab or window
iCanQuit
Learn how to quit smoking
opens in a new tab or window
Home
Medical oncology
Sarcoma
Bone sarcoma
11 results
Search
Ewing sarcoma IE (iFOSFamide and etoposide) (part 2 of VDC/IE)
Ewing sarcoma recurrent or metastatic irinotecan and temozolomide
Ewing sarcoma recurrent or metastatic TC (topotecan and CYCLOPHOSPHamide) INTERIM
Ewing sarcoma VDC (vinCRISTine, DOXOrubicin, CYCLOPHOSPHamide) (part 1 of VDC/IE)
Ewing sarcoma VDC/IE (vinCRISTine, DOXOrubicin, CYCLOPHOSPHamide/ iFOSFamide, etoposide) overview
Giant cell tumour of bone denosumab
Osteosarcoma MAP (methotrexate, DOXOrubicin, ciSplatin)
Ewing sarcoma VAC (vinCRISTine daCTINomycin CYCLOPHOSPHamide) (part 2a of VIDE followed by VAC or VAI) DISCONTINUED
Ewing sarcoma VAI (vinCRISTine daCTINomycin iFOSFamide) (part 2b of VIDE followed by VAC or VAI) DISCONTINUED
Ewing sarcoma VIDE (vinCRISTine iFOSFamide DOXOrubicin etoposide) (part 1 of VIDE followed by VAC or VAI) DISCONTINUED
Ewing sarcoma VIDE followed by VAC or VAI overview DISCONTINUED
Title
Content